Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome Life Science Investing
Arrowhead Pharmaceuticals Announces Interim Clinical Data on RNAi-based Obesity Candidates Showing Weight Loss in Obese Patients with Diabetes and Improved Measures of Body Composition Life Science Investing
Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus Pharmaceutical Investing
Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center
